Syngene International Limited’s Board of Directors has approved the un-audited financial results for the quarter and half-year ended September 30, 2026. The results, presented on a standalone and consolidated basis as per Indian Accounting Standards (Ind-AS), were considered and approved during the board meeting held on October 27, 2026. These unaudited financial results, along with the Limited Review Reports, have been submitted to the stock exchanges.
Board Approves Financial Results for Q2 FY27
Syngene International Limited announced today, October 27, 2026, that its Board of Directors, during a meeting held on the same day, has reviewed and approved the un-audited financial results for the quarter and the half-year ended September 30, 2026. These financial statements have been prepared in compliance with Indian Accounting Standards (Ind-AS), encompassing both standalone and consolidated figures.
Key Financial Information Submitted
The approved unaudited financial results, detailing the company’s performance for the second quarter and the first half of the fiscal year, have been submitted to the BSE Limited and the National Stock Exchange of India Limited. Accompanying these results are the Limited Review Reports, which have also been furnished to the regulatory bodies. The company confirmed that this information will be made available on its official website, www.syngeneintl.com.
Meeting Details
The Board Meeting, where these significant financial decisions were made, commenced at 15:15 IST and concluded at 18:30 IST on October 27, 2026.
Financial Highlights (Consolidated)
The unaudited consolidated financial results for the quarter and half-year ended September 30, 2026, reveal several key figures:
Quarter Ended September 30, 2026 (Unaudited)
- Total Income: ₹8,607 million
- Total Expenses: ₹8,070 million
- Profit before tax: ₹470 million
- Profit for the period: ₹322 million
- Total Comprehensive Income: ₹429 million
Half Year Ended September 30, 2026 (Unaudited)
- Total Income: ₹16,220 million
- Total Expenses: ₹15,740 million
- Profit before tax: ₹278 million
- Profit for the period: ₹232 million
- Total Comprehensive Income: ₹692 million
Financial Highlights (Standalone)
The unaudited standalone financial results for the same periods show:
Quarter Ended September 30, 2026 (Unaudited)
- Total Income: ₹8,054 million
- Total Expenses: ₹7,297 million
- Profit before tax: ₹690 million
- Profit for the period: ₹487 million
- Total Comprehensive Income: ₹503 million
Half Year Ended September 30, 2026 (Unaudited)
- Total Income: ₹14,932 million
- Total Expenses: ₹14,140 million
- Profit before tax: ₹590 million
- Profit for the period: ₹466 million
- Total Comprehensive Income: ₹761 million
These results provide an insight into Syngene’s financial performance during the specified periods.
Source: BSE
